Axcelis Tech downgraded by B. Riley Securities with a new price target
$ACLS
Industrial Machinery/Components
Technology
B. Riley Securities downgraded Axcelis Tech from Buy to Neutral and set a new price target of $50.00
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/2/2025 | $105.00 | Hold → Buy | The Benchmark Company |
| 4/21/2025 | $50.00 | Buy → Neutral | B. Riley Securities |
| 2/12/2025 | Outperform → Mkt Perform | William Blair | |
| 11/8/2024 | Buy → Hold | The Benchmark Company | |
| 5/3/2024 | $130.00 | Hold → Buy | Craig Hallum |
| 12/15/2023 | Buy → Neutral | BofA Securities | |
| 9/15/2023 | $225.00 | Buy | BofA Securities |
| 8/4/2023 | $140.00 → $175.00 | Buy → Hold | Craig Hallum |
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
The Benchmark Company upgraded Axcelis Tech from Hold to Buy and set a new price target of $105.00
B. Riley Securities downgraded Axcelis Tech from Buy to Neutral and set a new price target of $50.00
William Blair downgraded Axcelis Tech from Outperform to Mkt Perform
425 - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
8-K - AXCELIS TECHNOLOGIES INC (0001113232) (Filer)
425 - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
Diversifies Portfolio with Complementary Capital Equipment Solutions and Expands Addressable Markets Supported by Secular Tailwinds Greater R&D Scale to Fuel Differentiated, Next-Generation Technologies for Customers Resilient Pro-Forma Operating Profile and Balance Sheet to Support Investment in Organic Growth Initiatives and Share Repurchase Program Expected to be Accretive to Non-GAAP Earnings Per Share Within the First Year Post Closing Will Host Joint Conference Call and Webcast Today at 8:30 AM ET BEVERLY, Mass., and PLAINVIEW, N.Y., Oct. 1, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) and Veeco Instruments Inc. (NASDAQ:VECO) today announced that they have entered in
BEVERLY, Mass., Sept. 9, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, will be participating in the International Conference on Silicon Carbide and Related Materials (ICSCRM 2025) taking place September 14 - 19, 2025, at the Bexco Convention Center in Busan, South Korea. During the conference, Axcelis will be promoting the launch of the Company's new Purion Power Series+™ and GSD Ovation ES platforms, designed specifically to enable improved device capability and producti
BEVERLY, Mass., Sept. 8, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, has announced the launch of the Company's GSD Ovation™ ES high current ion implanter, targeted specifically for engineered substrates. Executive Vice President Dr. Greg Redinbo, commented, "We're excited to introduce the GSD Ovation ES. The GSD Ovation ES enables best-in-class high current Hydrogen & Helium implant capability for engineered substrate applications, including wafer splitting. The system
Diversifies Portfolio with Complementary Capital Equipment Solutions and Expands Addressable Markets Supported by Secular Tailwinds Greater R&D Scale to Fuel Differentiated, Next-Generation Technologies for Customers Resilient Pro-Forma Operating Profile and Balance Sheet to Support Investment in Organic Growth Initiatives and Share Repurchase Program Expected to be Accretive to Non-GAAP Earnings Per Share Within the First Year Post Closing Will Host Joint Conference Call and Webcast Today at 8:30 AM ET BEVERLY, Mass., and PLAINVIEW, N.Y., Oct. 1, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) and Veeco Instruments Inc. (NASDAQ:VECO) today announced that they have entered in
Q2 Highlights: Revenue of $194.5 millionGAAP Gross Margin of 44.9%, and Non-GAAP Gross Margin of 45.2%GAAP Operating Margin of 14.9% and Non-GAAP Operating Margin of 17.7%GAAP Diluted earnings per share of $0.98, and Non-GAAP Diluted earnings per share of $1.13BEVERLY, Mass., Aug. 5, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) today announced financial results for the second quarter ended June 30, 2025. President and CEO Russell Low commented, "Axcelis delivered strong results in the second quarter despite the cyclical digestion period in many of our markets,
BEVERLY, Mass., July 17, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry will release financial results for the second quarter 2025 before the opening of the market on Tuesday, August 5, 2025. The Company will host a call the same day to discuss the results at 8:30 a.m. ET. The call will be available via webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com, or by registering as a participant here:https://register-conf.media-server.co
The Company Announces Planned Retirement of Doug Lawson, Executive Vice President of Corporate Marketing and Strategy BEVERLY, Mass., June 27, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, today named David Ryzhik as Senior Vice President of Investor Relations and Corporate Strategy, assuming responsibility for the role in July 2024. The Company also announced the retirement of Doug Lawson, Executive Vice President of Corporate Marketing and Strategy. Mr. Lawson plans to retire in July 2024 and will remain as a Senior Advisor through July 2025.
BEVERLY, Mass., April 2, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today a shipment of the Company's Purion EXE™ SiC high energy implanter as well as a successful Purion H200™ SiC medium energy implanter evaluation closure at leading power device chipmakers located in Japan. The systems will be used for 150mm and 200mm production of silicon carbide power devices supporting automotive, industrial, energy, and other power intensive applications. Greg Redinbo,
SOLANA BEACH, Calif., July 15, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global therapy-enabling platform company providing navigation and delivery to the brain, is pleased to announce that Lynnette C. Fallon has been appointed to the Company's Board of Directors effective immediately. Ms. Fallon will also become a member of the Company's Audit Committee. Ms. Fallon is the Executive Vice President, HR/Legal, General Counsel and Secretary of Axcelis Technologies, Inc. (NASDAQ:ACLS), a provider of equipment and service solutions for the semiconductor manufacturing industry, with locations in eight countries. Ms. Fallon has held her current position sin
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)